MYD88 and melanoma: Moreover, the MyD88/IL-1R axis, downstream of IL-1 signaling, has been demonstrated to regulate PD-1/PD-L1 expression in melanoma-associated immune cells (81), again in line with the PD-1/PD-L1 expression in RDEB mouse immune cells.